Annual Retained Earnings
-$506.26 M
-$28.24 M-5.91%
December 31, 2023
Summary
- As of February 20, 2025, ADMA annual retained earnings is -$506.26 million, with the most recent change of -$28.24 million (-5.91%) on December 31, 2023.
- During the last 3 years, ADMA annual retained earnings has fallen by -$165.79 million (-48.70%).
- ADMA annual retained earnings is now -445547.89% below its all-time high of -$113.60 thousand, reached on June 1, 2010.
Performance
ADMA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$420.48 M
+$35.91 M+7.87%
September 30, 2024
Summary
- As of February 20, 2025, ADMA quarterly retained earnings is -$420.48 million, with the most recent change of +$35.91 million (+7.87%) on September 30, 2024.
- Over the past year, ADMA quarterly retained earnings has stayed the same.
- ADMA quarterly retained earnings is now -370039.96% below its all-time high of -$113.60 thousand, reached on June 30, 2010.
Performance
ADMA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ADMA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.9% | 0.0% |
| 3 y3 years | -48.7% | +12.0% |
| 5 y5 years | -133.9% | +12.0% |
ADMA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -22.8% | at low | -2.0% | +16.9% |
| 5 y | 5-year | -91.2% | at low | -58.8% | +16.9% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +16.9% |
ADMA Biologics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$420.48 M(-7.9%) |
| Jun 2024 | - | -$456.39 M(-6.6%) |
| Mar 2024 | - | -$488.45 M(-3.5%) |
| Dec 2023 | -$506.26 M(+5.9%) | -$506.26 M(+3.6%) |
| Sep 2023 | - | -$488.61 M(-0.5%) |
| Jun 2023 | - | -$491.18 M(+1.3%) |
| Mar 2023 | - | -$484.81 M(+1.4%) |
| Dec 2022 | -$478.02 M(+16.0%) | -$478.02 M(+2.6%) |
| Sep 2022 | - | -$465.79 M(+3.3%) |
| Jun 2022 | - | -$450.89 M(+3.1%) |
| Mar 2022 | - | -$437.12 M(+6.1%) |
| Dec 2021 | -$412.11 M(+21.0%) | -$412.11 M(+4.2%) |
| Sep 2021 | - | -$395.46 M(+4.7%) |
| Jun 2021 | - | -$377.75 M(+5.3%) |
| Mar 2021 | - | -$358.85 M(+5.4%) |
| Dec 2020 | -$340.47 M(+28.6%) | -$340.47 M(+6.0%) |
| Sep 2020 | - | -$321.06 M(+5.6%) |
| Jun 2020 | - | -$304.14 M(+7.1%) |
| Mar 2020 | - | -$283.96 M(+7.3%) |
| Dec 2019 | -$264.72 M(+22.3%) | -$264.72 M(+4.2%) |
| Sep 2019 | - | -$254.16 M(+4.7%) |
| Jun 2019 | - | -$242.72 M(+5.8%) |
| Mar 2019 | - | -$229.51 M(+6.0%) |
| Dec 2018 | -$216.44 M(+43.6%) | -$216.44 M(+9.1%) |
| Sep 2018 | - | -$198.40 M(+8.3%) |
| Jun 2018 | - | -$183.26 M(+8.8%) |
| Mar 2018 | - | -$168.52 M(+11.8%) |
| Dec 2017 | -$150.69 M | -$150.69 M(+9.4%) |
| Sep 2017 | - | -$137.71 M(+12.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | -$122.51 M(+8.0%) |
| Mar 2017 | - | -$113.47 M(+6.1%) |
| Dec 2016 | -$106.93 M(+22.3%) | -$106.93 M(+4.5%) |
| Sep 2016 | - | -$102.38 M(+4.4%) |
| Jun 2016 | - | -$98.04 M(+6.5%) |
| Mar 2016 | - | -$92.03 M(+5.3%) |
| Dec 2015 | -$87.42 M(+25.9%) | -$87.42 M(+5.5%) |
| Sep 2015 | - | -$82.84 M(+6.6%) |
| Jun 2015 | - | -$77.73 M(+6.4%) |
| Mar 2015 | - | -$73.06 M(+5.2%) |
| Dec 2014 | -$69.45 M(+31.9%) | -$69.45 M(+5.4%) |
| Sep 2014 | - | -$65.89 M(+5.4%) |
| Jun 2014 | - | -$62.50 M(+6.8%) |
| Mar 2014 | - | -$58.54 M(+11.2%) |
| Dec 2013 | -$52.64 M(+41.8%) | -$52.64 M(+9.8%) |
| Sep 2013 | - | -$47.94 M(+5.9%) |
| Jun 2013 | - | -$45.25 M(+12.1%) |
| Mar 2013 | - | -$40.35 M(+8.7%) |
| Dec 2012 | -$37.11 M(>+9900.0%) | -$37.11 M(+6.5%) |
| Sep 2012 | - | -$34.86 M(+10.3%) |
| Jun 2012 | - | -$31.61 M(+4.0%) |
| Mar 2012 | - | -$30.41 M(>+9900.0%) |
| Dec 2011 | - | -$153.60 K(+5.8%) |
| Sep 2011 | - | -$145.20 K(+3.6%) |
| Jun 2011 | -$140.10 K(+23.3%) | -$140.10 K(+9.0%) |
| Mar 2011 | - | -$128.50 K(+4.0%) |
| Dec 2010 | - | -$123.50 K(+8.7%) |
| Jun 2010 | - | -$113.60 K |
| Jun 2010 | -$113.60 K | - |
FAQ
- What is ADMA Biologics annual retained earnings?
- What is the all time high annual retained earnings for ADMA Biologics?
- What is ADMA Biologics annual retained earnings year-on-year change?
- What is ADMA Biologics quarterly retained earnings?
- What is the all time high quarterly retained earnings for ADMA Biologics?
- What is ADMA Biologics quarterly retained earnings year-on-year change?
What is ADMA Biologics annual retained earnings?
The current annual retained earnings of ADMA is -$506.26 M
What is the all time high annual retained earnings for ADMA Biologics?
ADMA Biologics all-time high annual retained earnings is -$113.60 K
What is ADMA Biologics annual retained earnings year-on-year change?
Over the past year, ADMA annual retained earnings has changed by -$28.24 M (-5.91%)
What is ADMA Biologics quarterly retained earnings?
The current quarterly retained earnings of ADMA is -$420.48 M
What is the all time high quarterly retained earnings for ADMA Biologics?
ADMA Biologics all-time high quarterly retained earnings is -$113.60 K
What is ADMA Biologics quarterly retained earnings year-on-year change?
Over the past year, ADMA quarterly retained earnings has changed by $0.00 (0.00%)